Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Baris Gencer, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gencer B, Mach F, Murphy SA, De Ferrari GM, Huber K, Lewis BS, Ferreira J, Kurtz CE, Wang H, Honarpour N, Keech AC, Sever PS, Pedersen TR, Sabatine MS, Giugliano RP. Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial. JAMA Cardiol. 2020 May 20. PMID: 32432684.
    Citations:    
  2. Gencer B, Mach F, Guo J, Im K, Ruzza A, Wang H, Kurtz CE, Pedersen TR, Keech AC, Ott BR, Sabatine MS, Giugliano RP. Cognition After Lowering LDL-Cholesterol With Evolocumab. J Am Coll Cardiol. 2020 May 12; 75(18):2283-2293. PMID: 32381158.
    Citations:    
  3. Gencer B, Li XS, Gurmu Y, Bonaca MP, Morrow DA, Cohen M, Bhatt DL, Steg PG, Storey RF, Johanson P, Wang Z, Hazen SL, Sabatine MS. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial. J Am Heart Assoc. 2020 May 18; 9(10):e015331. PMID: 32366163.
    Citations:    
  4. Mongin D, Caparros AU, Gateau J, Gencer B, Alvero-Cruz JR, Cheval B, Cullati S, Courvoisier DS. Dynamical System Modeling of Self-Regulated Systems Undergoing Multiple Excitations: First Order Differential Equation Approach. Multivariate Behav Res. 2020 May 02; 1-20. PMID: 32363935.
    Citations:    
  5. Marston NA, Gurmu Y, Melloni GEM, Bonaca M, Gencer B, Sever PS, Pedersen TR, Keech AC, Roselli C, Lubitz SA, Ellinor PT, O'Donoghue ML, Giugliano RP, Ruff CT, Sabatine MS. The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism. Circulation. 2020 May 19; 141(20):1600-1607. PMID: 32223429.
    Citations:    
  6. Gencer B, Moutzouri E, Blum MR, Feller M, Collet TH, Delgiovane C, da Costa BR, Buffle E, Monney P, Gabus V, Müller H, Sykiotis GP, Kearney P, Gussekloo J, Westendorp R, Stott DJ, Bauer DC, Rodondi N. The Impact of Levothyroxine on Cardiac Function in Older Adults With Mild Subclinical Hypothyroidism: A Randomized Clinical Trial. Am J Med. 2020 Mar 12. PMID: 32171774.
    Citations:    
  7. Mahendiran T, Nanchen D, Meier D, Gencer B, Klingenberg R, Räber L, Carballo D, Matter CM, Lüscher TF, Windecker S, Mach F, Rodondi N, Muller O, Fournier S. Optimal Timing of Invasive Coronary Angiography following NSTEMI. J Interv Cardiol. 2020; 2020:8513257. PMID: 32206045.
    Citations:    
  8. Gencer B, Mach F. Potential of Lipoprotein(a)-Lowering Strategies in Treating Coronary Artery Disease. Drugs. 2020 Feb; 80(3):229-239. PMID: 31916186.
    Citations:    
  9. Gencer B, Carballo D, Nanchen D, Koskinas KC, Klingenberg R, Räber L, Auer R, Carballo S, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F. Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort. Int J Cardiol. 2020 03 15; 303:8-13. PMID: 31859113.
    Citations:    
  10. Mahendiran T, Nanchen D, Gencer B, Meier D, Klingenberg R, Räber L, Carballo D, Matter CM, Lüscher TF, Windecker S, Mach F, Rodondi N, Muller O, Fournier S. Prognosis of Patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary Syndromes. J Cardiovasc Transl Res. 2019 Nov 25. PMID: 31768948.
    Citations:    
  11. Pagano S, Magenta A, D'Agostino M, Martino F, Barillà F, Satta N, Frias MA, Ronca A, Mach F, Gencer B, Favari E, Vuilleumier N. Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation. J Clin Med. 2019 Nov 21; 8(12). PMID: 31766415.
    Citations:    
  12. Winzap P, Davies A, Klingenberg R, Obeid S, Roffi M, Mach F, Räber L, Windecker S, Templin C, Nietlispach F, Nanchen D, Gencer B, Muller O, Matter CM, von Eckardstein A, Lüscher TF. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61. Cardiovasc Diabetol. 2019 10 31; 18(1):142. PMID: 31672144.
    Citations:    
  13. Butty A, Gencer B, Koskinas KC, Carballo D, Räber L, Klingenberg R, Matter CM, Lüscher TF, Windecker S, Muller O, Rodondi N, Mach F, Nanchen D. Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors. Int J Cardiol. 2020 01 15; 299:289-295. PMID: 31668506.
    Citations:    
  14. Stämpfli SF, Donati TG, Hellermann J, Anwer S, Erhart L, Gruner C, Kaufmann BA, Gencer B, Haager PK, Müller H, Tanner FC. Right ventricle and outcome in left ventricular non-compaction cardiomyopathy. J Cardiol. 2020 Jan; 75(1):20-26. PMID: 31587941.
    Citations:    
  15. Gencer B, Mach F. Gender Specificity and Interpretation of Functional Cardiac Imaging: Let's Talk about Sex. Thromb Haemost. 2019 Sep; 119(9):1379-1381. PMID: 31473990.
    Citations:    
  16. Koskinas KC, Windecker S, Pedrazzini G, Mueller C, Cook S, Matter CM, Muller O, Häner J, Gencer B, Crljenica C, Amini P, Deckarm O, Iglesias JF, Räber L, Heg D, Mach F. Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS). J Am Coll Cardiol. 2019 11 19; 74(20):2452-2462. PMID: 31479722.
    Citations:    
  17. Vuilleumier N, Pagano S, Combescure C, Gencer B, Virzi J, Räber L, Carballo D, Carballo S, Nanchen D, Rodondi N, Windecker S, Hazen SL, Wang Z, Li XS, von Eckardstein A, Matter CM, Lüscher TF, Klingenberg R, Mach F. Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes. J Clin Med. 2019 Jul 09; 8(7). PMID: 31324073.
    Citations:    
  18. Gencer B, Vuilleumier N, Nanchen D, Collet TH, Klingenberg R, Räber L, Auer R, Carballo D, Carballo S, Aghlmandi S, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F. Prognostic value of total testosterone levels in patients with acute coronary syndromes. Eur J Prev Cardiol. 2019 Jun 01; 2047487319853343. PMID: 31154826.
    Citations:    
  19. Gencer B, Rigamonti F, Nanchen D, Vuilleumier N, Kern I, Aghlmandi S, Klingenberg R, Räber L, Auer R, Carballo D, Carballo S, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F. Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes. Eur J Clin Invest. 2019 Jul; 49(7):e13117. PMID: 30937890.
    Citations:    
  20. Jaquet E, Gencer B, Auer R, Moschetti K, Muller O, Matter CM, Lüscher TF, Mach F, Rodondi N, Bodenmann P, Nanchen D. Association between income and control of cardiovascular risk factors after acute coronary syndromes: an observational study. Swiss Med Wkly. 2019 Apr 08; 149:w20049. PMID: 30994923.
    Citations:    
  21. Nanchen D, Klingenberg R, Gencer B, Räber L, Carballo D, von Eckardstein A, Windecker S, Rodondi N, Lüscher TF, Mach F, Muller O, Matter CM. Inflammation during acute coronary syndromes - Risk of cardiovascular events and bleeding. Int J Cardiol. 2019 07 15; 287:13-18. PMID: 31003794.
    Citations:    
  22. Carballo D, Rodondi N, Auer R, Carballo S, Nanchen D, Räber L, Klingenberg R, Keller PF, Heg D, Jüni P, Muller O, Matter CM, Lüscher TF, Windecker S, Mach F, Gencer B. Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention. PLoS One. 2019; 14(2):e0211464. PMID: 30789921.
    Citations:    
  23. Gencer B, Pagano S, Vuilleumier N, Satta N, Delhumeau-Cartier C, Meier C, Bavamian S, Montecucco F, Mach F, Calmy A. Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort. Atherosclerosis. 2019 05; 284:253-259. PMID: 30827714.
    Citations:    
  24. Koskinas KC, Windecker S, Buhayer A, Gencer B, Pedrazzini G, Mueller C, Cook S, Muller O, Matter CM, Räber L, Heg D, Mach F. Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial. Clin Cardiol. 2018 Dec; 41(12):1513-1520. PMID: 30421481.
    Citations:    Fields:    
  25. Stähli BE, Wischnewsky MB, Jakob P, Klingenberg R, Obeid S, Heg D, Räber L, Windecker S, Mach F, Gencer B, Nanchen D, Jüni P, Landmesser U, Matter CM, Lüscher TF, Maier W. Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography. Catheter Cardiovasc Interv. 2019 01 01; 93(1):16-24. PMID: 30291678.
    Citations:    Fields:    
  26. Blum MR, Gencer B, Adam L, Feller M, Collet TH, da Costa BR, Moutzouri E, Dopheide J, Depairon M, Sykiotis GP, Kearney P, Gussekloo J, Westendorp R, Stott DJ, Bauer DC, Rodondi N. Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial. J Clin Endocrinol Metab. 2018 08 01; 103(8):2988-2997. PMID: 29846630.
    Citations:    Fields:    
  27. Harbaoui B, Nanchen D, Lantelme P, Gencer B, Heg D, Klingenberg R, Räber L, Carballo D, Matter CM, Windecker S, Mach F, Rodondi N, Eeckhout E, Monney P, Antiochos P, Schwitter J, Pascale P, Fournier S, Courand PY, Lüscher TF, Muller O. Prognostic value of pulse pressure after an acute coronary syndrome. Atherosclerosis. 2018 10; 277:219-226. PMID: 30033338.
    Citations:    Fields:    
  28. Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, De Backer G, Hegele RA, Hovingh GK, Jacobson TA, Krauss RM, Laufs U, Leiter LA, März W, Nordestgaard BG, Raal FJ, Roden M, Santos RD, Stein EA, Stroes ES, Thompson PD, Tokgözoglu L, Vladutiu GD, Gencer B, Stock JK, Ginsberg HN, Chapman MJ. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018 07 14; 39(27):2526-2539. PMID: 29718253.
    Citations: 2     Fields:    
  29. Gencer B, Mach F. Lipoprotein(a): the perpetual supporting actor. Eur Heart J. 2018 07 14; 39(27):2597-2599. PMID: 30010823.
    Citations:    Fields:    
  30. Gencer B, Mach F. Lipid management in ACS: Should we go lower faster? Atherosclerosis. 2018 08; 275:368-375. PMID: 30015301.
    Citations:    Fields:    
  31. Gencer B, Rigamonti F, Nanchen D, Klingenberg R, Räber L, Moutzouri E, Auer R, Carballo D, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F, Roffi M. Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study. Eur Heart J Acute Cardiovasc Care. 2018 Jun 01; 2048872618777819. PMID: 29862825.
    Citations:    Fields:    
  32. Stähli BE, Wischnewsky MB, Jakob P, Klingenberg R, Obeid S, Heg D, Räber L, Windecker S, Roffi M, Mach F, Gencer B, Nanchen D, Jüni P, Landmesser U, Matter CM, Lüscher TF, Maier W. Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes. Int J Cardiol. 2018 Nov 01; 270:7-13. PMID: 29885826.
    Citations: 1     Fields:    
  33. Koskinas KC, Zanchin T, Klingenberg R, Gencer B, Temperli F, Baumbach A, Roffi M, Moschovitis A, Muller O, Tüller D, Stortecky S, Mach F, Lüscher TF, Matter CM, Pilgrim T, Heg D, Windecker S, Räber L. Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction. J Am Heart Assoc. 2018 04 13; 7(8). PMID: 29654204.
    Citations:    Fields:    
  34. Canivell S, Muller O, Gencer B, Heg D, Klingenberg R, Räber L, Carballo D, Matter C, Lüscher T, Windecker S, Mach F, Rodondi N, Nanchen D. Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome. PLoS One. 2018; 13(4):e0195174. PMID: 29649323.
    Citations:    Fields:    Translation:Humans
  35. Obeid S, Yousif N, Schelldorfer A, Shahin M, Räber L, Gencer B, Mach F, Roffi M, Matter CM, Windecker S, Lüscher TF. Short-Term Outcome After Left Main Interventions in Patients Presenting With Acute Coronary Syndrome. J Invasive Cardiol. 2018 03; 30(3):98-104. PMID: 29493510.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  36. Gencer B, Nanchen D, Collet TH, Rodondi N, Mach F. [Current update on PCKS9 inhibitors]. Rev Med Suisse. 2018 Feb 28; 14(596):482-486. PMID: 29489129.
    Citations:    Fields:    
  37. Floriani C, Gencer B, Collet TH, Rodondi N. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J. 2018 02 14; 39(7):503-507. PMID: 28329380.
    Citations: 6     Fields:    
  38. Gencer B, Mach F. So low… so far so good: neurocognitive impact of lowering LDL-C levels with PCSK9 inhibitors. Eur Heart J. 2018 02 01; 39(5):382-384. PMID: 29346544.
    Citations:    Fields:    
  39. Satta N, Pagano S, Montecucco F, Gencer B, Mach F, Kaiser L, Calmy A, Vuilleumier N. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients. J Infect. 2018 02; 76(2):186-195. PMID: 29198606.
    Citations:    Fields:    
  40. Klingenberg R, Aghlmandi S, Liebetrau C, Räber L, Gencer B, Nanchen D, Carballo D, Akhmedov A, Montecucco F, Zoller S, Brokopp C, Heg D, Jüni P, Marti Soler H, Marques-Vidal PM, Vollenweider P, Dörr O, Rodondi N, Mach F, Windecker S, Landmesser U, von Eckardstein A, Hamm CW, Matter CM, Lüscher TF. Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes. Eur Heart J. 2017 Dec 14; 38(47):3493-3502. PMID: 29155984.
    Citations:    Fields:    Translation:Humans
  41. Frias MA, Virzi J, Golaz O, Gencer B, Mach F, Vuilleumier N. Impact of long distance rowing on biological health: A pilot study. Clin Biochem. 2018 Feb; 52:142-147. PMID: 29198760.
    Citations:    Fields:    Translation:Humans
  42. Gencer B, Koskinas KC, Räber L, Karagiannis A, Nanchen D, Auer R, Carballo D, Carballo S, Klingenberg R, Heg D, Matter CM, Lüscher TF, Rodondi N, Mach F, Windecker S. Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes. J Am Heart Assoc. 2017 Nov 09; 6(11). PMID: 29122809.
    Citations:    Fields:    Translation:Humans
  43. Landmesser U, Chapman MJ, Farnier M, Gencer B, Gielen S, Hovingh GK, Lüscher TF, Sinning D, Tokgözoglu L, Wiklund O, Zamorano JL, Pinto FJ, Catapano AL. European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk. Eur Heart J. 2017 08 01; 38(29):2245-2255. PMID: 27789571.
    Citations: 18     Fields:    
  44. Gencer B, Kronenberg F, Stroes ES, Mach F. Lipoprotein(a): the revenant. Eur Heart J. 2017 May 21; 38(20):1553-1560. PMID: 28329241.
    Citations: 2     Fields:    Translation:Humans
  45. Aghlmandi S, Schärer N, Heg D, Räber L, Zwahlen M, Gencer B, Nanchen D, Carballo D, Carballo S, Jüni P, von Eckardstein A, Landmesser U, Rodondi N, Mach F, Windecker S, Matter CM, Lüscher TF, Klingenberg R. Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort. Eur Heart J Acute Cardiovasc Care. 2018 Sep; 7(6):522-531. PMID: 28425755.
    Citations:    Fields:    Translation:Humans
  46. Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Räber L, Windecker S, Rodondi N, Nanchen D, Muller O, Miranda MX, Matter CM, Wu Y, Li L, Wang Z, Alamri HS, Gogonea V, Chung YM, Tang WH, Hazen SL, Lüscher TF. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J. 2017 Mar 14; 38(11):814-824. PMID: 28077467.
    Citations: 24     Fields:    Translation:Humans
  47. Tadler M, Rüegg E, Niquille M, Gencer B, Gautschi OP, Pittet-Cuénod B, Modarressi A. Multi-organ injuries due to a lightning strike: a case report highlighting the importance of a multi-disciplinary approach. Case Reports Plast Surg Hand Surg. 2017; 4(1):1-4. PMID: 28164145.
    Citations:    
  48. Klingenberg R, Aghlmandi S, Räber L, Gencer B, Nanchen D, Heg D, Carballo S, Rodondi N, Mach F, Windecker S, Jüni P, von Eckardstein A, Matter CM, Lüscher TF. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score. Eur Heart J Acute Cardiovasc Care. 2018 Mar; 7(2):129-138. PMID: 28029055.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  49. Gencer B, Mach F, Burnand B. Rev Med Suisse. 2016 Dec 07; 12(542):2136. PMID: 28700168.
    Citations:    Fields:    Translation:Humans
  50. Gencer B, Rodondi N, Mach F. New concepts in the management of dyslipidaemiaa. Swiss Med Wkly. 2016; 146:w14378. PMID: 27878791.
    Citations:    Fields:    Translation:Humans
  51. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S. [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome). 2016 10; 17(10):831-872. PMID: 27869901.
    Citations: 6     Fields:    
  52. Auer R, Gencer B, Tango R, Nanchen D, Matter CM, Lüscher TF, Windecker S, Mach F, Cornuz J, Humair JP, Rodondi N. Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisons. BMJ Open. 2016 09 20; 6(9):e011520. PMID: 27650761.
    Citations:    Fields:    Translation:Humans
  53. Laurencet ME, Girardin F, Rigamonti F, Bevand A, Meyer P, Carballo D, Roffi M, Noble S, Mach F, Gencer B. Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay. PLoS One. 2016; 11(8):e0161493. PMID: 27551861.
    Citations:    Fields:    Translation:Humans
  54. Gencer B, Nanchen D. Identifying familial hypercholesterolemia in acute coronary syndrome. Curr Opin Lipidol. 2016 08; 27(4):375-81. PMID: 27092769.
    Citations: 2     Fields:    Translation:Humans
  55. Nanchen D, Gencer B, Muller O, Auer R, Aghlmandi S, Heg D, Klingenberg R, Räber L, Carballo D, Carballo S, Matter CM, Lüscher TF, Windecker S, Mach F, Rodondi N. Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes. Circulation. 2016 Sep 06; 134(10):698-709. PMID: 27462068.
    Citations: 4     Fields:    Translation:Humans
  56. Rigamonti F, Gencer B, Rey F, Chaara J, Tessitore E, Bunwaree S, Meier P, Noble S, Grosgurin O, Larribau R, Windecker S, Carbone F, Montecucco F, Rodondi N, Matter CM, Luscher TF, Mach F, Roffi M. Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial procedures. Eur J Intern Med. 2016 Nov; 35:83-88. PMID: 27436141.
    Citations:    Fields:    Translation:Humans
  57. Malinauskaite I, Slapikas R, Courvoisier D, Mach F, Gencer B. The fear of dying and occurrence of posttraumatic stress symptoms after an acute coronary syndrome: A prospective observational study. J Health Psychol. 2017 02; 22(2):208-217. PMID: 26311815.
    Citations:    Fields:    Translation:Humans
  58. Rigamonti F, Montecucco F, Boroli F, Rey F, Gencer B, Cikirikcioglu M, Reverdin S, Carbone F, Noble S, Roffi M, Banfi C, Giraud R. The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation. Int J Cardiol. 2016 Oct 15; 221:741-5. PMID: 27428314.
    Citations: 1     Fields:    Translation:Humans
  59. Gencer B, Rodondi N. Evidence and controversies regarding the screening for subclinical hypothyroidism in patients with cardiovascular disease. J Thorac Dis. 2016 Jun; 8(6):E446-50. PMID: 27294253.
    Citations:    
  60. Roffi M, Müller C, Valgimigli M, Windecker S, Gencer B. [Highlights from the 2015 ESC NSTE-ACS Guidelines]. Rev Med Suisse. 2016 May 25; 12(520):1014-9. PMID: 27424341.
    Citations: 1     Fields:    Translation:Humans
  61. Gencer B, Rodondi N, Auer R, Nanchen D, Räber L, Klingenberg R, Pletscher M, Jüni P, Windecker S, Matter CM, Lüscher TF, Mach F, Perneger TV, Girardin FR. Health utility indexes in patients with acute coronary syndromes. Open Heart. 2016; 3(1):e000419. PMID: 27252878.
    Citations:    
  62. Roffi M, Gencer B, Storey RF, Andreotti F, Patrono C. Clinical Perspectives and Pearls from the 2015 ESC NSTE-ACS Guidelines. Curr Cardiol Rep. 2016 May; 18(5):48. PMID: 27068306.
    Citations: 1     Fields:    Translation:Humans
  63. Laaksonen R, Ekroos K, Sysi-Aho M, Hilvo M, Vihervaara T, Kauhanen D, Suoniemi M, Hurme R, März W, Scharnagl H, Stojakovic T, Vlachopoulou E, Lokki ML, Nieminen MS, Klingenberg R, Matter CM, Hornemann T, Jüni P, Rodondi N, Räber L, Windecker S, Gencer B, Pedersen ER, Tell GS, Nygård O, Mach F, Sinisalo J, Lüscher TF. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J. 2016 Jul 01; 37(25):1967-76. PMID: 27125947.
    Citations:    
  64. Noble S, Tessitore E, Gencer B, Righini M, Robert-Ebadi H, Roffi M, Bonvini RF. A Randomized Study of SheathLess vs Standard Guiding Catheters for Transradial Percutaneous Coronary Interventions. Can J Cardiol. 2016 12; 32(12):1425-1432. PMID: 27381263.
    Citations: 2     Fields:    Translation:Humans
  65. Aubert CE, Gencer B, Rodondi N. [Recommendations for management of dyslipidemia in 2016 in Switzerland]. Rev Med Suisse. 2016 Mar 02; 12(508):430-4. PMID: 27089598.
    Citations:    Fields:    Translation:HumansPHPublic Health
  66. Gencer B, Rodondi N, Mach F. [PCSK9 inhibitors: new treatment to lower cholesterol]. Rev Med Suisse. 2016 Mar 02; 12(508):440-2, 444. PMID: 27089600.
    Citations:    Fields:    Translation:Humans
  67. Welker J, Auer R, Gencer B, Muller O, Cornuz J, Matter CM, Mach F, Windecker S, Rodondi N, Nanchen D. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland. Swiss Med Wkly. 2016; 146:w14275. PMID: 26859223.
    Citations:    Fields:    Translation:HumansPHPublic Health
  68. Gencer B, Rodondi N. Should we screen for hypothyroidism in patients with cardiovascular disease? Eur Heart J. 2016 07 07; 37(26):2066-8. PMID: 26763791.
    Citations: 2     Fields:    Translation:Humans
  69. Gencer B, Rodondi N. Should we screen cardiovascular patients for thyroid dysfunction? Eur Heart J. 2015 Dec 14; 36(47):3306-9. PMID: 27042720.
    Citations:    Fields:    Translation:Humans
  70. Gencer B, Auer R, de Rekeneire N, Butler J, Kalogeropoulos A, Bauer DC, Kritchevsky SB, Miljkovic I, Vittinghoff E, Harris T, Rodondi N. Association between resistin levels and cardiovascular disease events in older adults: The health, aging and body composition study. Atherosclerosis. 2016 Feb; 245:181-6. PMID: 26724528.
    Citations: 9     Fields:    Translation:Humans
  71. Gencer B, Montecucco F, Nanchen D, Carbone F, Klingenberg R, Vuilleumier N, Aghlmandi S, Heg D, Räber L, Auer R, Jüni P, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F. Prognostic value of PCSK9 levels in patients with acute coronary syndromes. Eur Heart J. 2016 Feb 07; 37(6):546-53. PMID: 26655339.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  72. Gencer B, Mach F. Testosterone: a hormone preventing cardiovascular disease or a therapy increasing cardiovascular events? Eur Heart J. 2016 Dec 21; 37(48):3569-3575. PMID: 26637832.
    Citations:    
  73. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S. 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Rev Esp Cardiol (Engl Ed). 2015 Dec; 68(12):1125. PMID: 26675199.
    Citations: 10     Fields:    
  74. Gencer B, Laaksonen R, Buhayer A, Mach F. Use and role of monoclonal antibodies and other biologics in preventive cardiology. Swiss Med Wkly. 2015; 145:w14179. PMID: 26524671.
    Citations: 1     Fields:    Translation:HumansAnimalsPHPublic Health
  75. Gencer B, Girardin F. Coronary artery disease is associated with persistent lower quality of life in women. Open Heart. 2015; 2(1):e000305. PMID: 26435841.
    Citations:    
  76. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016 Jan 14; 37(3):267-315. PMID: 26320110.
    Citations: 389     Fields:    Translation:Humans
  77. Kamani CH, Gencer B, Montecucco F, Courvoisier D, Vuilleumier N, Meyer P, Mach F. Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population. Eur J Clin Invest. 2015 Oct; 45(10):1017-24. PMID: 26081791.
    Citations: 1     Fields:    Translation:Humans
  78. Poncet A, Gencer B, Blondon M, Gex-Fabry M, Combescure C, Shah D, Schwartz PJ, Besson M, Girardin FR. Correction: Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis. PLoS One. 2015; 10(7):e0133108. PMID: 26172274.
    Citations:    Fields:    
  79. Nanchen D, Gencer B, Auer R, Räber L, Stefanini GG, Klingenberg R, Schmied CM, Cornuz J, Muller O, Vogt P, Jüni P, Matter CM, Windecker S, Lüscher TF, Mach F, Rodondi N. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes. Eur Heart J. 2015 Sep 21; 36(36):2438-45. PMID: 26142466.
    Citations: 9     Fields:    Translation:Humans
  80. Räber L, Klingenberg R, Heg D, Kelbæk H, Roffi M, Tüller D, Baumbach A, Zanchin T, Carballo D, Ostojic M, Stefanini GG, Rodondi N, von Birgelen C, Moschovitis A, Engstrøm T, Gencer B, Auer R, Meier B, Mach F, Lüscher TF, Jüni P, Matter CM, Windecker S. Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study. JACC Cardiovasc Interv. 2015 Jul; 8(8):1064-1074. PMID: 26205445.
    Citations: 1     Fields:    Translation:Humans
  81. Poncet A, Gencer B, Blondon M, Gex-Fabry M, Combescure C, Shah D, Schwartz PJ, Besson M, Girardin FR. Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis. PLoS One. 2015; 10(6):e0127213. PMID: 26070071.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  82. Selby K, Nanchen D, Auer R, Gencer B, Räber L, Klingenberg R, Blum M, Marques-Vidal P, Cornuz J, Muller O, Vogt P, Jüni P, Matter CM, Windecker S, Lüscher TF, Mach F, Rodondi N. Low statin use in adults hospitalized with acute coronary syndrome. Prev Med. 2015 Aug; 77:131-6. PMID: 26007299.
    Citations: 2     Fields:    Translation:Humans
  83. Gencer B, Lambert G, Mach F. PCSK9 inhibitors. Swiss Med Wkly. 2015; 145:w14094. PMID: 25856746.
    Citations: 2     Fields:    Translation:Humans
  84. Gencer B, Mach F. Sweetless'n low LDL-C targets for PCSK9 treatment. Eur Heart J. 2015 May 14; 36(19):1146-8. PMID: 25827601.
    Citations: 2     Fields:    Translation:Humans
  85. Klingenberg R, Heg D, Räber L, Carballo D, Nanchen D, Gencer B, Auer R, Jaguszewski M, Stähli BE, Jakob P, Templin C, Stefanini GG, Meier B, Vogt P, Roffi M, Maier W, Landmesser U, Rodondi N, Mach F, Windecker S, Jüni P, Lüscher TF, Matter CM. Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland. Heart. 2015 Jun; 101(11):854-63. PMID: 25794517.
    Citations: 5     Fields:    Translation:Humans
  86. Gencer B, Rodondi N, Auer R, Räber L, Klingenberg R, Nanchen D, Carballo D, Vogt P, Carballo S, Meyer P, Matter CM, Windecker S, Lüscher TF, Mach F. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes. Eur J Intern Med. 2015 Jan; 26(1):56-62. PMID: 25582072.
    Citations: 5     Fields:    Translation:Humans
  87. Gencer B, Auer R, Nanchen D, Räber L, Klingenberg R, Carballo D, Blum M, Vogt P, Carballo S, Meyer P, Matter CM, Windecker S, Lüscher TF, Mach F, Rodondi N. Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes. Atherosclerosis. 2015 Mar; 239(1):118-24. PMID: 25585031.
    Citations: 4     Fields:    Translation:Humans
  88. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S. [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]. Kardiol Pol. 2015; 73(12):1207-94. PMID: 26727671.
    Citations: 3     Fields:    Translation:Humans
  89. Gencer B, Butler J, Bauer DC, Auer R, Kalogeropoulos A, Marques-Vidal P, Applegate WB, Satterfield S, Harris T, Newman A, Vittinghoff E, Rodondi N. Association of electrocardiogram abnormalities and incident heart failure events. Am Heart J. 2014 Jun; 167(6):869-75.e3. PMID: 24890537.
    Citations: 6     Fields:    Translation:Humans
  90. Auer R, Gencer B, Räber L, Klingenberg R, Carballo S, Carballo D, Nanchen D, Cornuz J, Vader JP, Vogt P, Jüni P, Matter CM, Windecker S, Lüscher TF, Mach F, Rodondi N. Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications. PLoS One. 2014; 9(3):e93147. PMID: 24676282.
    Citations: 3     Fields:    Translation:Humans
  91. Gencer B, Collet TH, Virgini V, Auer R, Rodondi N. Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies. Endocr Metab Immune Disord Drug Targets. 2013 Mar; 13(1):4-12. PMID: 23369133.
    Citations: 10     Fields:    Translation:Humans
  92. Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR, Nanchen D, den Elzen WP, Balmer P, Luben RN, Iacoviello M, Triggiani V, Cornuz J, Newman AB, Khaw KT, Jukema JW, Westendorp RG, Vittinghoff E, Aujesky D, Rodondi N. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 2012 Aug 28; 126(9):1040-9. PMID: 22821943.
    Citations: 71     Fields:    Translation:Humans
  93. Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Åsvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, Maisonneuve P, Cornuz J, Newman AB, Khaw KT, Westendorp RG, Franklyn JA, Vittinghoff E, Walsh JP, Rodondi N. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012 May 28; 172(10):799-809. PMID: 22529182.
    Citations: 71     Fields:    Translation:Humans
  94. Gencer B, Moradpour D, Rodondi N. [Lipid-lowering treatment and liver dysfunction]. Rev Med Suisse. 2012 Mar 07; 8(331):507-8, 510-2. PMID: 22471112.
    Citations:    Fields:    Translation:Humans
  95. Alatri A, Tribout B, Gencer B, Calanca L, Mazzolai L. [Thrombotic risk in assisted reproductive technology]. Rev Med Suisse. 2011 Feb 09; 7(281):357-60. PMID: 21416715.
    Citations: 1     Fields:    Translation:Humans
  96. Bösner S, Haasenritter J, Becker A, Karatolios K, Vaucher P, Gencer B, Herzig L, Heinzel-Gutenbrunner M, Schaefer JR, Abu Hani M, Keller H, Sönnichsen AC, Baum E, Donner-Banzhoff N. Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule. CMAJ. 2010 Sep 07; 182(12):1295-300. PMID: 20603345.
    Citations: 25     Fields:    Translation:Humans
  97. Gencer B, Vaucher P, Herzig L, Verdon F, Ruffieux C, Bösner S, Burnand B, Bischoff T, Donner-Banzhoff N, Favrat B. Ruling out coronary heart disease in primary care patients with chest pain: a clinical prediction score. BMC Med. 2010 Jan 21; 8:9. PMID: 20092615.
    Citations: 19     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Gencer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (267)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.